文献速递皮肤肿瘤

深度学习卷积神经网络辅助肢端雀斑样黑素瘤检测的决策增强研究

Augmented decision-making for acral lentiginous melanoma detection using deep convolutional neural networks.
PubMed 文献 · J Eur Acad Dermatol Venereol · 2020-01-31

本研究开发了用于检测肢端雀斑样黑素瘤(ALM)的卷积神经网络(CNN),并通过60名皮肤科医生的三阶段调查评估其辅助决策效果。结果显示,加入CNN预测后,医生的ALM检测准确率从74.7%提升至86.9%,且医生间一致性显著提高。

要点

  • CNN辅助可显著提高医生对ALM的初始诊断准确率。
  • CNN辅助能改善医生间诊断一致性。
  • CNN可作为医生的辅助决策支持系统。

核心结论

  • CNN辅助决策提高了专家医生对ALM的检测性能及决策一致性,显示其作为辅助决策支持系统的潜力。

研究设计与样本

  • 使用1072张皮肤镜图像(肢端良性痣、ALM及中间性肿瘤)训练CNN;60名医生完成三阶段调查:仅皮肤镜图像、增加临床信息、再增加CNN预测。

主要发现

  • ALM检测准确率:第一阶段74.7%(95%CI 72.6-76.8%),第二阶段79.0%(95%CI 76.7-81.2%),第三阶段86.9%(95%CI 85.3-88.4%)。
  • 第三阶段准确率较第一阶段提高12.2%p(95%CI 10.1-14.3%p),较第二阶段提高7.9%p(95%CI 6.0-9.9%p)。
  • 医生间一致性Fleiss-κ:第一阶段0.436(95%CI 0.437-0.573),第二阶段0.506(95%CI 0.621-0.749),第三阶段0.684(95%CI 0.621-0.749)。

关键数值与推荐

  • CNN辅助决策后,ALM检测准确率提升至86.9%,较仅皮肤镜图像时提高12.2个百分点。

临床怎么用

  • 临床中可将CNN作为辅助工具,结合皮肤镜图像、临床信息及CNN预测进行ALM检测决策。

局限性

  • 原文未明确报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Several studies have achieved high-level performance of melanoma detection using convolutional neural networks (CNNs). However, few have described the extent to which the implementation of CNNs improves the diagnostic performance of the physicians. OBJECTIVE: This study is aimed at developing a CNN for detecting acral lentiginous melanoma (ALM) and investigating whether its implementation can improve the initial decision for ALM detection made by the physicians. METHODS: A CNN was trained using 1072 dermoscopic images of acral benign nevi, ALM and intermediate tumours. To investigate whether the implementation of CNN can improve the initial decision for ALM detection, 60 physicians completed a three-stage survey. In Stage I, they were asked for their decisions solely on the basis of dermoscopic images provided to them. In Stage II, they were also provided with clinical information. In Stage III, they were provided with the additional diagnosis and probability predicted by the CNN. RESULTS: The accuracy of ALM detection in the participants was 74.7% (95% confidence interval [CI], 72.6-76.8%) in Stage I and 79.0% (95% CI, 76.7-81.2%) in Stage II. In Stage III, it was 86.9% (95% CI, 85.3-88.4%), which exceeds the accuracy delivered in Stage I by 12.2%p (95% CI, 10.1-14.3%p) and Stage II by 7.9%p (95% CI, 6.0-9.9%p). Moreover, the concordance between the participants considerably increased (Fleiss-κ of 0.436 [95% CI, 0.437-0.573] in Stage I, 0.506 [95% CI, 0.621-0.749] in Stage II and 0.684 [95% CI, 0.621-0.749] in Stage III). CONCLUSIONS: Augmented decision-making improved the performance of and concordance between the clinical decisions of a diverse group of experts. This study demonstrates the potential use of CNNs as an adjoining, decision-supporting system for physicians' decisions.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Lee S, Chu YS, Yoo SK, et al. Augmented decision-making for acral lentiginous melanoma detection using deep convolutional neural networks. J Eur Acad Dermatol Venereol. 2020. PMID: 31919901. doi:10.1111/jdv.16185

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。